纯自主性衰竭中的生活质量和残疾:不仅仅是前进性同核蛋白病变
Ilaria Cani1, Giannicola Carrozzo2, Flavia Baccari3
1U.O.C. Clinica Neurologica Rete Metropolitana (NeuroMet), IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Parkinsonism & related disorders
|November 20, 2025
概括
纯自主性衰竭 (PAF) 显著影响生活质量和功能独立性,自主性症状与残疾密切相关. 这项研究强调了PAF的残疾性质和干预的必要性.
科学领域:
- 神经学 神经学
- 自主神经科学 自主神经科学
- 生活质量研究 研究 生命质量研究
背景情况:
- 纯自主性衰竭 (PAF) 是一种神经退行性疾病,导致广泛的自主功能障碍.
- 有限的研究存在于与健康相关的生活质量 (HRQoL) 和PAF患者的残疾.
研究的目的:
- 评估PAF患者的HRQoL和残疾.
- 研究PAF的临床特征,自主症状,HRQoL和残疾之间的关系.
主要方法:
- 对30名PAF患者进行横截面研究.
- 使用SF-36用于HRQoL,以及ADL,IADL,mBI用于残疾评估.
- 分析了临床数据,自主症状,HRQoL和残疾之间的关联.
主要成果:
- PAF患者报告HRQoL明显低于一般人群,特别是在身体领域.
- 一半的参与者在日常活动中表现出轻微的依赖,尿路控制受到影响最多.
- 自主症状与身体HRQoL和残疾有很强的相关性;弹性缓解了这种关系.
结论:
- 这项研究是首次检查HRQoL,残疾及其与PAF自主功能障碍的联系.
- PAF是一种残疾状况,严重影响生活质量和功能独立性.
- 研究结果强调需要有针对性的干预措施来改善患者的治疗结果.
关键词:
功能性损伤 功能性损伤健康状况 卫生状况非运动症状 非运动症状正静性低血压是正静性的.帕金森症 帕金森症产节性疾病是一种病.α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies.相关概念视频
Disorders of the Autonomic Nervous System
1.4K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.4K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Nephrotic Syndrome I : Introduction
476
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
476
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


